Return
Postoperative Gabapentinoid Use Is Associated with Improved Survival in Glioblastoma: A Nationwide Population-Based Study
S
E
E
B
A
S
N
N
S
I
E
E
M
J
DOI:10.1093/noajnl/vdag162.png)
Abstract
En 中文
Glioblastoma (GBM) is a highly aggressive primary brain tumor that can integrate into neural circuits implicated in tumor progression and treatment resistance. Gabapentinoids are proposed to disrupt such interactions. We analyzed postoperative gabapentinoid use and overall survival (OS) in nationwide adult GBM cohort.
Journal
N
IF:
4.1
Papers:
1.5K
Citations:
3.2K
